Find activities

128 results

  • Guidance for best practice management - National Bowel Screening Programme

    The National Bowel Screening Programme (NBSP) is a significant investment in reducing disease and death from one of New Zealand’s biggest cancer killers. The NBSP is our first screening programme for both men and women and, when fully implemented, is expected to detect 500 to 700 cancers every year, in the early stages. The development of these clinical guidelines aims to embed best practice clinical management across the screening pathway and ensure quality and consistency. More
    Opened 26 November 2018

  • Proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products

    Medsafe is seeking comments on a proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products. This risk was identified by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. The MHRA have received reports in which an individual using one or more paraffin-based skin product has died after their clothes and/or bedding caught fire. The MHRA published a reminder for healthcare professionals in April 2016 . ... More
    Opened 26 October 2018

  • Weight Management Tools

    This short survey will help the Ministry of Health to have a better understanding of growth and weight monitoring in New Zealand and how Practice Management Systems could assist health practitioners with this task. More
    Opened 17 September 2018

  • Strategy to Prevent and Minimise Gambling Harm 2019/20 to 2021/22

    This document seeks your comment on the proposed future direction and content of the Ministry of Health’s Strategy to Prevent and Minimise Gambling Harm 2019/20 to 2021/22. Your feedback is vital to help us develop the final strategy. Included are draft proposals for: the strategic plan, which sets out the general strategic direction and priorities that provides a framework for the activities described below the proposed funding levels for the Ministry, in... More
    Opened 20 August 2018

  • Consultation on the Draft National Ethics Standards for Health and Disability Research

    The National Ethics Advisory Committee (NEAC) is an independent advisor to the Minister of Health. NEAC was established in 2001 by section 16 of the New Zealand Public Health and Disability Act 2000. The National Ethics Advisory Committee’s statutory functions are to: provide advice to the Minister of Health on ethical issues of national significance in respect of any health and disability matters (including research and health services) determine nationally consistent... More
    Opened 24 July 2018

  • Proposed changes to the National Health Index (NHI) system and HISO 10046, the Consumer Health Identity Standard

    The Ministry of Health is considering undertaking a number of changes to the National Health Index (NHI) system. Changes made will be included in the associated Consumer Health Identity Standard . We seek comment to assist in establishing a) if a particular proposal should proceed at a concept level, and b) a relative priority for each proposal. Some changes are essential to maintaining the operating life of the NHI system – for example, the proposed extension to the NHI numbering... More
    Opened 9 July 2018

  • Posthumous Reproduction: A review of the current Guidelines for the Storage, Use, and Disposal of Sperm from a Deceased Man to take into account gametes and embryos

    Posthumous reproduction involves the use of a person’s sperm or eggs, after their death. In some cases, it also involves the retrieval of these gametes very shortly after death or at a time when death is imminent. While scientific advances have made this form of reproduction possible, there are many complex ethical and legal issues that have not yet been resolved. For example, the existing Guidelines, written in 2000 apply only to the posthumous use of sperm that was retrieved prior to the... More
    Opened 3 July 2018

  • Update to the Guideline on the Regulation of Therapeutic Products – Part 11: Clinical trials

    This consultation is aimed at pharmaceutical companies, health care professional organisations, and individuals involved in conducting, or who are subjects of, clinical trials of medicines. Medsafe sought comment on a major revision of the Guideline on the Regulation of Therapeutic Products in New Zealand. Part 11: Clinical trials – regulatory approval and good clinical practice requirements. Part 11 of the regulatory guideline was last reviewed in January 2015. Since then,... More
    Opened 22 June 2018
128 results. Page 5 of 5